The novel approach of tirzepatide peptide represents a exciting advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide065611.activablog.com/40965647/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment